27/09/17 -"Tough times ahead"
27/09/17 -"Tough times ahead"
We diagnose chronic illness for the sector as its long-held pricing tooth decays and accountability is forced upon it.
This study discovers and explains why life won’t be same (or as good) again!
Our Lead Analyst on Healthcare & Pharma has published her latest note entitled “Tough times ahead”.
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
| Corporate broking | NO |
| Trading in corporate shares | NO |
| Analyst ownership | NO |
| Advising of corporate (strategy, marketing, debt, etc) | NO |
| Research paid for by corporate | NO |
| Provision of corporate access paid for by corporate | NO |
| Link between and a banking entity | NO |
| Brokerage activity at AlphaValue | NO |